|
1
|
Shibata MA, Kavanaugh C, Shibata E, Abe H,
Nguyen P, Otsuki Y, Trepel JB and Green JE: Comparative effects of
lovastatin on mammary and prostate oncogenesis in transgenic mouse
models. Carcinogenesis. 24:453–459. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuhajda FP, Pizer ES, Li JN, Mani NS,
Frehywot GL and Townsend CA: Synthesis and antitumor activity of an
inhibitor of fatty acid synthase. Proc Natl Acad Sci USA.
97:3450–3454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orita H, Coulter J, Tully E, Kuhajda FP
and Gabrielson E: Inhibiting fatty acid synthase for
chemoprevention of chemically induced lung tumors. Clin Cancer Res.
14:2458–2464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pizer ES, Chrest FJ, DiGiuseppe JA and Han
WF: Pharmacological inhibitors of mammalian fatty acid synthase
suppress DNA replication and induce apoptosis in tumor cell lines.
Cancer Res. 58:4611–4615. 1998.PubMed/NCBI
|
|
5
|
Wong WW, Dimitroulakos J, Minden MD and
Penn LZ: HMG-CoA reductase inhibitors and the malignant cell: The
statin family of drugs as triggers of tumor-specific apoptosis.
Leukemia. 16:508–519. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kridel SJ, Axelrod F, Rozenkrantz N and
Smith JW: Orlistat is a novel inhibitor of fatty acid synthase with
antitumor activity. Cancer Res. 64:2070–2075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chuang HY, Chang YF and Hwang JJ:
Antitumor effect of orlistat, a fatty acid synthase inhibitor, is
via activation of caspase-3 on human colorectal carcinoma-bearing
animal. Biomed Pharmacother. 65:286–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carvalho MA, Zecchin KG, Seguin F, Bastos
DC, Agostini M, Rangel AL, Veiga SS, Raposo HF, Oliveira HC, Loda
M, et al: Fatty acid synthase inhibition with Orlistat promotes
apoptosis and reduces cell growth and lymph node metastasis in a
mouse melanoma model. Int J Cancer. 123:2557–2565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Notarnicola M, Messa C, Refolo MG, Tutino
V, Miccolis A and Caruso MG: Synergic effect of eicosapentaenoic
acid and lovastatin on gene expression of HMGCoA reductase and LDL
receptor in cultured HepG2 cells. Lipids Health Dis. 9:1352010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barone M, Notarnicola M, Caruso MG, Scavo
MP, Viggiani MT, Tutino V, Polimeno L, Pesetti B, Di Leo A and
Francavilla A: Olive oil and omega-3 polyunsaturated fatty acids
suppress intestinal polyp growth by modulating the apoptotic
process in ApcMin/+ mice. Carcinogenesis. 35:1613–1619.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barone M, Tanzi S, Lofano K, Scavo MP,
Guido R, Demarinis +L, Principi MB, Bucci A and Di Leo A:
Estrogens, phytoestrogens and colorectal neoproliferative lesions.
Genes Nutr. 3:7–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barone M, Scavo MP, Papagni S, Piscitelli
D, Guido R, Di Lena M, Comelli MC and Di Leo A: ERβ expression in
normal, adenomatous and carcinomatous tissues of patients with
familial adenomatous polyposis. Scand J Gastroenterol.
45:1320–1328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Konstantinopoulos PA, Kominea A, Vandoros
G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G
and Papavassiliou AG: Oestrogen receptor beta (ERbeta) is
abundantly expressed in normal colonic mucosa, but declines in
colon adenocarcinoma paralleling the tumour's dedifferentiation.
Eur J Cancer. 39:1251–1258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rudolph A, Toth C, Hoffmeister M, Roth W,
Herpel E, Jansen L, Marx A, Brenner H and Chang-Claude J:
Expression of oestrogen receptor β and prognosis of colorectal
cancer. Br J Cancer. 107:831–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Leo A, Barone M, Maiorano E, Tanzi S,
Piscitelli D, Marangi S, Lofano K, Ierardi E, Principi M and
Francavilla A: ER-beta expression in large bowel adenomas:
Implications in colon carcinogenesis. Dig Liver Dis. 40:260–266.
2008. View Article : Google Scholar
|
|
16
|
Weihua Z, Andersson S, Cheng G, Simpson
ER, Warner M and Gustafsson JA: Update on estrogen signaling. FEBS
Lett. 546:17–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas C and Gustafsson JA: The different
roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer.
11:597–608. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gulino A, Ferretti E and De Smaele E:
Hedgehog signalling in colon cancer and stem cells. EMBO Mol Med.
1:300–302. 2009. View Article : Google Scholar
|
|
19
|
Wang H, Li YY, Wu YY and Nie YQ:
Expression and clinical significance of hedgehog signaling pathway
related components in colorectal cancer. Asian Pac J Cancer Prev.
13:2319–2324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kameda C, Nakamura M, Tanaka H, Yamasaki
A, Kubo M, Tanaka M, Onishi H and Katano M: Oestrogen
receptor-alpha contributes to the regulation of the hedgehog
signalling pathway in ERalpha-positive gastric cancer. Br J Cancer.
102:738–747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bian YH, Huang SH, Yang L, Ma XL, Xie JW
and Zhang HW: Sonic hedgehog-Gli1 pathway in colorectal
adenocarcinomas. World J Gastroenterol. 13:1659–1665. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kinoshita Y, Jarell AD, Flaman JM, Foltz
G, Schuster J, Sopher BL, Irvin DK, Kanning K, Kornblum HI, Nelson
PS, et al: Pescadillo, a novel cell cycle regulatory protein
abnormally expressed in malignant cells. J Biol Chem.
276:6656–6665. 2001. View Article : Google Scholar
|
|
23
|
Maiorana A, Tu X, Cheng G and Baserga R:
Role of pescadillo in the transformation and immortalization of
mammalian cells. Oncogene. 23:7116–7124. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie W, Feng Q, Su Y, Dong B, Wu J, Meng L,
Qu L and Shou C: Transcriptional regulation of PES1 expression by
c-Jun in colon cancer. PLoS One. 7:e422532012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng L, Li J, Han Y, Lin J, Niu C, Zhou
Z, Yuan B, Huang K, Li J, Jiang K, et al: PES1 promotes breast
cancer by differentially regulating ERα and ERβ. J Clin Invest.
122:2857–2870. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dey P, Barros RP, Warner M, Ström A and
Gustafsson JA: Insight into the mechanisms of action of estrogen
receptor β in the breast, prostate, colon, and CNS. J Mol
Endocrinol. 51:T61–T74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Papapolychroniadis C, Kaimakis D,
Giannoulis K, Papadopoulos V, Zatagias A, Halvatzoulis O,
Kostopoulos J, Kokkonis G, Giala M and Harlaftis N: Metachronous
breast carcinoma (second malignancy), following 'cure' from
colorectal carcinoma. Tech Coloproctol. 8(Suppl 1): s129–s131.
2004. View Article : Google Scholar
|
|
28
|
Büller NV, Rosekrans SL, Metcalfe C,
Heijmans J, van Dop WA, Fessler E, Jansen M, Ahn C, Vermeulen JL,
Westendorp BF, et al: Stromal Indian hedgehog signaling is required
for intestinal adenoma formation in mice. Gastroenterology.
148:170–180.e6. 2015. View Article : Google Scholar
|
|
29
|
Notarnicola M, Tutino V, Caruso MG and
Francavilla A: n-3 polyunsaturated fatty acids reverse the
development of polyps in ApcMin/+ transgenic mice. Oncol
Rep. 35:504–510. 2016.
|
|
30
|
Garcia SB, Barros LT, Turatti A,
Martinello F, Modiano P, Ribeiro-Silva A, Vespúcio MV and Uyemura
SA: The anti-obesity agent Orlistat is associated to increase in
colonic preneoplastic markers in rats treated with a chemical
carcinogen. Cancer Lett. 240:221–224. 2006. View Article : Google Scholar
|
